Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.
about
Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic responseBurden of illness of rheumatoid arthritis in Latin America: a regional perspectiveThe Obesity Epidemic and Consequences for Rheumatoid Arthritis CareObesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases).Inflammatory focal bone destruction in femoral heads with end-stage haemophilic arthropathy: a study on clinic samples with micro-CT and histological analysesJoint-specific assessment of swelling and power Doppler in obese rheumatoid arthritis patientsPredictors of longterm changes in body mass index in rheumatoid arthritis.Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons.Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis.Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations.Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis.Are obesity, ACPAs and periodontitis conditions that influence the risk of developing rheumatoid arthritis in first-degree relatives?Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.The impact of obesity on the development and progression of rheumatoid arthritis.Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).Predictors of severe radiographic progression in patients with early rheumatoid arthritis: A Prospective observational cohort study.Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
P2860
Q26778275-B27D5B82-8875-49EA-8A4E-B0683EB34442Q26798332-915C5108-0B7A-4EAE-8965-C966FEB397BFQ28074864-A7C84686-D461-4D11-871F-9700D061E5ECQ34488394-90D5F7D2-C1D6-4D34-A826-D46C1C47713CQ36216958-2CE079A6-7806-4D16-85D9-614B838AB287Q36297290-EC0A517A-FEBF-4D13-AE12-7F38A3A39573Q36784187-4F214E0D-C28C-4EB9-BFD4-56FBD3B82215Q37031387-7FCAA598-E803-4359-9B99-32D195A3AFB6Q37358808-164A743C-E470-4F18-829C-871603C69FCBQ38617817-E00C3F94-A007-4710-90A0-AC38983C3A4EQ38763702-C7A3654D-4384-4E8C-B183-1333876B2307Q38829639-5013BC88-4AB5-4A6B-AFA0-96D8D1463261Q39999268-2F308358-1817-44C5-9D49-5C65F30A38FAQ40405276-224A97C0-AF57-44BC-99AF-9E9725F402A8Q41544053-0F64EDA2-AEC1-47B1-A960-94C43E0BB3ABQ45189725-03A05528-0106-4F05-87EC-5BBFCBE22767Q45940053-BE11D4EA-8C07-47F9-B955-A714B8E25E97Q51013068-EA20DC75-61F2-4B91-A113-3A86C5456B23Q51333035-87550922-EFF7-412B-8B8B-12F6721321A3Q55267199-8A109F3C-B318-4F1E-9A49-5E227B24392D
P2860
Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1-2 years.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@ast
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en-gb
type
label
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@ast
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en-gb
prefLabel
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@ast
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en-gb
P2093
P2860
P1476
Greater body mass independentl ...... X-ray and MRI over 1-2 years.
@en
P2093
Daniel G Baker
Joshua F Baker
Justine Shults
Michael George
Mikkel Ostergaard
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205544
P407
P577
2014-08-04T00:00:00Z
P6179
1009889997